David Gerring
Corporate Officer/Principal at ARECOR THERAPEUTICS PLC
Net worth: 264 284 $ as of 29/04/2024
Profile
David Gerring has held positions as Vice President of Development at Arecor Ltd.
and Vice President of Business Development at Arecor Therapeutics Plc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARECOR THERAPEUTICS PLC
0.50% | 15/11/2022 | 154,626 ( 0.50% ) | 264 284 $ | 29/04/2024 |
David Gerring active positions
| Companies | Position | Start |
|---|---|---|
| ARECOR THERAPEUTICS PLC | Corporate Officer/Principal | - |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ARECOR THERAPEUTICS PLC | Health Technology |
| Private companies | 1 |
|---|---|
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- David Gerring
